[DPHARMA] QoQ TTM Result on 30-Jun-2016 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
22-Aug-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Jun-2016 [#2]
Profit Trend
QoQ- -3.57%
YoY- 4.9%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 354,464 312,940 328,308 327,738 304,911 271,040 232,663 32.36%
PBT 32,714 31,479 42,709 46,824 47,508 49,765 46,157 -20.49%
Tax -5,098 -4,653 -9,379 -11,087 -9,864 -10,980 -8,786 -30.40%
NP 27,616 26,826 33,330 35,737 37,644 38,785 37,371 -18.24%
-
NP to SH 27,890 27,115 34,022 36,314 37,659 38,785 34,569 -13.32%
-
Tax Rate 15.58% 14.78% 21.96% 23.68% 20.76% 22.06% 19.04% -
Total Cost 326,848 286,114 294,978 292,001 267,267 232,255 195,292 40.91%
-
Net Worth 463,071 454,703 451,913 510,978 457,740 270,323 268,530 43.75%
Dividend
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Div 19,142 19,142 8,084 8,084 5,682 5,682 25,710 -17.83%
Div Payout % 68.64% 70.60% 23.76% 22.26% 15.09% 14.65% 74.38% -
Equity
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Net Worth 463,071 454,703 451,913 510,978 457,740 270,323 268,530 43.75%
NOSH 278,959 278,959 278,959 278,959 278,959 278,959 278,959 0.00%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 7.79% 8.57% 10.15% 10.90% 12.35% 14.31% 16.06% -
ROE 6.02% 5.96% 7.53% 7.11% 8.23% 14.35% 12.87% -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 127.07 112.18 117.69 102.62 109.24 162.43 139.50 -6.02%
EPS 10.00 9.72 12.20 11.37 13.49 23.24 20.73 -38.46%
DPS 6.86 6.86 2.90 2.53 2.04 3.41 15.42 -41.69%
NAPS 1.66 1.63 1.62 1.60 1.64 1.62 1.61 2.05%
Adjusted Per Share Value based on latest NOSH - 278,959
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
RPS 36.85 32.53 34.13 34.07 31.70 28.18 24.19 32.35%
EPS 2.90 2.82 3.54 3.78 3.91 4.03 3.59 -13.25%
DPS 1.99 1.99 0.84 0.84 0.59 0.59 2.67 -17.78%
NAPS 0.4814 0.4727 0.4698 0.5312 0.4759 0.281 0.2792 43.74%
Price Multiplier on Financial Quarter End Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 -
Price 2.31 1.98 2.06 2.04 2.55 2.62 2.72 -
P/RPS 1.82 1.76 1.75 1.99 2.33 1.61 1.95 -4.49%
P/EPS 23.10 20.37 16.89 17.94 18.90 11.27 13.12 45.75%
EY 4.33 4.91 5.92 5.57 5.29 8.87 7.62 -31.37%
DY 2.97 3.47 1.41 1.24 0.80 1.30 5.67 -34.99%
P/NAPS 1.39 1.21 1.27 1.28 1.55 1.62 1.69 -12.20%
Price Multiplier on Announcement Date
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Date 22/05/17 24/02/17 21/11/16 22/08/16 18/05/16 23/02/16 24/11/15 -
Price 2.32 2.23 2.10 2.14 2.40 2.61 2.70 -
P/RPS 1.83 1.99 1.78 2.09 2.20 1.61 1.94 -3.81%
P/EPS 23.20 22.94 17.22 18.82 17.79 11.23 13.03 46.85%
EY 4.31 4.36 5.81 5.31 5.62 8.91 7.68 -31.93%
DY 2.96 3.08 1.38 1.18 0.85 1.30 5.71 -35.44%
P/NAPS 1.40 1.37 1.30 1.34 1.46 1.61 1.68 -11.43%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment